Use of Low-Literacy Decision Aid to Enhance Knowledge and Reduce Decisional Conflict Among a Diverse Population of Adults With Rheumatoid Arthritis: Results of a Pilot Study

Arthritis Care and Research

Volumn 68, Issue 7, 2016, Pages 889-898

  Barton, Jennifer L ^a   Trupin, Laura ^b   Schillinger, Dean ^b   Evans Young, Gina ^b   Imboden, John ^b   Montori, Victor M ^c   Yelin, Edward ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG;

ADULT; ARTICLE; ATTITUDE TO HEALTH; CLINICAL DECISION MAKING; CONFLICT; CONTROLLED STUDY; DECISION SUPPORT SYSTEM; DOCTOR PATIENT RELATION; EDUCATIONAL STATUS; ETHNIC GROUP; FEASIBILITY STUDY; FEMALE; HEALTH LITERACY; HUMAN; IMMIGRANT; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT DECISION MAKING; PATIENT SATISFACTION; PILOT STUDY; PRACTICE GUIDELINE; RHEUMATOID ARTHRITIS;

EID: 84976524862     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22801     Document Type: Article

References (39)

1. Markusse IM, Dirven L, van Groenendael JH, Han KH, Ronday HK, Kerstens PJ, et al. Mortality in a large cohort of patients with early rheumatoid arthritis that were treated-to-target for 10 years [abstract]. Arthritis Rheum 2014;Suppl 1:S359.
2. Fidder HH, Singendonk MM, van der Have M, Oldenburg B, van Oijen MG. Low rates of adherence for tumor necrosis factor-α inhibitors in Crohn's disease and rheumatoid arthritis: results of a systematic review. World J Gastroenterol 2013;19:4344–50.
3. De Wit MP, Smolen JS, Gossec L, van der Heijde DM. Treating rheumatoid arthritis to target: the patient version of the international recommendations. Ann Rheum Dis 2011;70:891–5.
4. Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010;69:631–7.
5. Smolen JS, Landewe R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010;69:964–75.
6. Smolen JS, Landewe R, Breedveld FC, Buch M, Burmester G, Dougados M, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis 2014;73:492–509.
7. Barton JL, Trupin L, Tonner C, Imboden J, Katz P, Schillinger D, et al. English language proficiency, health literacy, and trust in physician are associated with shared decision making in rheumatoid arthritis. J Rheumatol 2014;41:1290–7.
8. McBurney CA, Vina ER. Racial and ethnic disparities in rheumatoid arthritis. Curr Rheumatol Rep 2012;14:463–71.
9. Bruce B, Fries JF, Murtagh KN. Health status disparities in ethnic minority patients with rheumatoid arthritis: a cross-sectional study. J Rheumatol 2007;34:1475–9.
10. Barton JL, Trupin L, Schillinger D, Gansky SA, Tonner C, Margaretten M, et al. Racial and ethnic disparities in disease activity and function among persons with rheumatoid arthritis from university-affiliated clinics. Arthritis Care Res (Hoboken) 2011;63:1238–46.
11. Caplan L, Wolfe F, Michaud K, Quinzanos I, Hirsh JM. Strong association of health literacy with functional status among rheumatoid arthritis patients: a cross-sectional study. Arthritis Care Res (Hoboken) 2014;66:508–14.
12. Barton JL, Schmajuk G, Trupin L, Graf J, Imboden J, Yelin EH, et al. Poor knowledge of methotrexate associated with older age and limited English-language proficiency in a diverse rheumatoid arthritis cohort. Arthritis Res Ther 2013;15:R157.
13. Barton JL, Evans-Young G, Trupin L, Anderson J, Ragouzeos D, Breslin M, et al. The design of a low literacy decision aid about rheumatoid arthritis medications developed in three languages for use during the clinical encounter. BMC Med Inform Decis Mak 2014;14:104.
14. John M. Eisenberg Center for Clinical Decisions and Communications Science. Drug therapy for rheumatoid arthritis: comparative effectiveness. Rockville (MD): Agency for Healthcare Research and Quality; 2007.
15. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24.
16. Baker DW, Williams MV, Parker RM, Gazmararian JA, Nurss J. Development of a brief test to measure functional health literacy. Patient Educ Couns 1999;38:33–42.
17. Nam JL, Ramiro S, Gaujoux-Viala C, Takase K, Leon-Garcia M, Emery P, et al. Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 2014;73:516–28.
18. Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 2008;59:762–84.
19. Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012;64:625–39.
20. Pincus T. A multidimensional health assessment questionnaire (MDHAQ) for all patients with rheumatic diseases to complete at all visits in standard clinical care. Bull NYU Hosp Jt Dis 2007;65:150–60.
21. Pincus T, Yazici Y, Bergman MJ. RAPID3, an index to assess and monitor patients with rheumatoid arthritis, without formal joint counts: similar results to DAS28 and CDAI in clinical trials and clinical care. Rheum Dis Clin North Am 2009;35:773–8.
22. Seligman HK, Wallace AS, de Walt DA, Schillinger D, Arnold CL, Shilliday BB, et al. Facilitating behavior change with low-literacy patient education materials. Am J Health Behav 2007;31 Suppl 1:S69–78.
23. Breslin M, Mullan RJ, Montori VM. The design of a decision aid about diabetes medications for use during the consultation with patients with type 2 diabetes. Patient Educ Couns 2008;73:465–72.
24. Mullan RJ, Montori VM, Shah ND, Christianson TJ, Bryant SC, Guyatt GH, et al. The diabetes mellitus medication choice decision aid: a randomized trial. Arch Intern Med 2009;169:1560–8.
25. Urrutia M, Campos S, O'Connor A. Validation of a Spanish version of the decisional conflict scale. Rev Med Chil 2008;136:1439–47. In Spanish.
26. O'Connor AM. Validation of a decisional conflict scale. Med Decis Making 1995;15:25–30.
27. Thom DH, Ribisl KM, Stewart AL, Luke DA, and the Stanford Trust Study Physicians. Further validation and reliability testing of the Trust in Physician Scale. Med Care 1999;37:510–7.
28. Stewart AL, Napoles-Springer A, Perez-Stable EJ. Interpersonal processes of care in diverse populations. Milbank Q 1999;77:305–39.
29. Stewart AL, Napoles-Springer AM, Gregorich SE, Santoyo-Olsson J. Interpersonal processes of care survey: patient-reported measures for diverse groups. Health Serv Res 2007;42 Pt 1:1235–56.
30. Schenker Y, Stewart A, Na B, Whooley MA. Depressive symptoms and perceived doctor-patient communication in the Heart and Soul study. J Gen Intern Med 2009;24:550–6.
31. Jerant A, DiMatteo R, Arnsten J, Moore-Hill M, Franks P. Self-report adherence measures in chronic illness: retest reliability and predictive validity. Med Care 2008;46:1134–9.
32. Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment: clinical applications. JAMA 2002;288:2880–3.
33. Stephenson BJ, Rowe BH, Haynes RB, Macharia WM, Leon G. The rational clinical examination: is this patient taking the treatment as prescribed? JAMA 1993;269:2779–81.
34. Salaffi F, Cimmino MA, Leardini G, Gasparini S, Grassi W. Disease activity assessment of rheumatoid arthritis in daily practice: validity, internal consistency, reliability and congruency of the Disease Activity Score including 28 joints (DAS28) compared with the Clinical Disease Activity Index (CDAI). Clin Exp Rheumatol 2009;27:552–9.
35. Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. J Rheumatol 2003;30:167–78.
36. Curtis JR, Yang S, Chen L, Pope JE, Keystone EC, Haraoui B, et al. Determining the minimally important difference in the Clinical Disease Activity Index for improvement and worsening in early rheumatoid arthritis. Arthritis Care Res (Hoboken) 2015;67:1345–53.
37. Wolfe F, Michaud K. Resistance of rheumatoid arthritis patients to changing therapy: discordance between disease activity and patients’ treatment choices. Arthritis Rheum 2007;56:2135–42.
38. Wyatt KD, Branda ME, Anderson RT, Pencille LJ, Montori VM, Hess EP, et al. Peering into the black box: a meta-analysis of how clinicians use decision aids during clinical encounters. Implement Sci 2014;9:26.
39. Coylewright M, Branda M, Inselman JW, Shah N, Hess E, LeBlanc A, et al. Impact of sociodemographic patient characteristics on the efficacy of decision aids: a patient-level meta-analysis of 7 randomized trials. Circ Cardiovasc Qual Outcomes 2014;7:360–7.